Glycopyrrolate Patent Expiration

Glycopyrrolate is Used for managing chronic obstructive pulmonary disease (COPD) through maintenance treatment of airflow obstruction. It was first introduced by Casper Pharma Llc in its drug Robinul on Approved Prior to Jan 1, 1982. Other drugs containing Glycopyrrolate are Lonhala Magnair Kit, Cuvposa, Seebri Neohaler, Glycopyrrolate, Robinul Forte, Glyrx-Pf, Dartisla Odt. 53 different companies have introduced drugs containing Glycopyrrolate.


Glycopyrrolate Patents

Given below is the list of patents protecting Glycopyrrolate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lonhala Magnair Kit US10744277 Aerosol delivery device and method of operating the aerosol delivery device Dec 07, 2036 Sumitomo Pharma Am
Lonhala Magnair Kit US10688518 Method of manufacturing a vibratable head for an aerosol generator and vibratable head for an aerosol generator Nov 12, 2036 Sumitomo Pharma Am
Lonhala Magnair Kit US10376661 Opening element for opening an ampoule in an aerosol generation device and aerosol generation device comprising the opening element Sep 14, 2035 Sumitomo Pharma Am
Lonhala Magnair Kit US9604018 Aerosol therapy device May 16, 2033 Sumitomo Pharma Am
Lonhala Magnair Kit US9168556 Membrane nebulizer and method for welding a membrane to a carrier during the production of a membrane nebulizer Sep 01, 2032 Sumitomo Pharma Am
Lonhala Magnair Kit US9789270 Inhalation therapy device comprising an ampoule for storing a medicament to be nebulized Oct 30, 2030 Sumitomo Pharma Am
Lonhala Magnair Kit US10940110 Method and system for the treatment of chronic COPD with nebulized anticholinergic administrations Feb 26, 2029 Sumitomo Pharma Am
Lonhala Magnair Kit US9265900 Disposable ampoule for an aerosol generating device Dec 07, 2028 Sumitomo Pharma Am
Seebri Neohaler US8182838 Dry powder composition comprising co-jet milled particles for pulmonary inhalation Oct 20, 2028 Novartis
Seebri Neohaler US8479730 Inhaler device Oct 11, 2028 Novartis
Lonhala Magnair Kit US11278683 Inhalation therapy device comprising an ampoule for storing a medicament to be nebulized Aug 16, 2026 Sumitomo Pharma Am
Lonhala Magnair Kit US7931212 Fluid droplet production apparatus and method Nov 25, 2025 Sumitomo Pharma Am
Lonhala Magnair Kit US7458372 Inhalation therapy device Nov 18, 2024

(Expired)

Sumitomo Pharma Am
Robinul US7091236 Method for increasing the bioavailability of glycopyrrolate Apr 24, 2024

(Expired)

Casper Pharma Llc
Robinul Forte US7091236 Method for increasing the bioavailability of glycopyrrolate Apr 24, 2024

(Expired)

Casper Pharma Llc
Lonhala Magnair Kit US8511581 Fluid droplet production apparatus and method Nov 08, 2023

(Expired)

Sumitomo Pharma Am
Cuvposa US7638552 Method for increasing the bioavailability of glycopyrrolate Aug 20, 2023

(Expired)

Merz Pharms
Cuvposa US7816396 Method for increasing the bioavailability of glycopyrrolate Aug 20, 2023

(Expired)

Merz Pharms
Lonhala Magnair Kit US7316067 Forming a perforate membrane by laser drilling and a subsequent electro-polishing step Sep 06, 2022

(Expired)

Sumitomo Pharma Am
Seebri Neohaler US7736670 Method of making particles for use in a pharmaceutical composition Jun 27, 2021

(Expired)

Novartis
Seebri Neohaler US8048451 Pharmaceutical compositions for inhalation Jun 27, 2021

(Expired)

Novartis
Seebri Neohaler US8303991 Method of making particles for use in a pharmaceutical composition Jun 27, 2021

(Expired)

Novartis
Seebri Neohaler US8435567 Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation Jun 27, 2021

(Expired)

Novartis
Seebri Neohaler US8580306 Particles for use in a pharmaceutical composition Jun 27, 2021

(Expired)

Novartis
Seebri Neohaler US8956661 Method of making composite particles for use in pharmaceutical compositions and composite particles and compositions thereof Jun 27, 2021

(Expired)

Novartis
Seebri Neohaler US9931304 Method of making particles for use in a pharmaceutical composition Jun 27, 2021

(Expired)

Novartis
Seebri Neohaler US9962338 Method of making particles for use in a pharmaceutical composition Jun 27, 2021

(Expired)

Novartis
Seebri Neohaler US7229607 Treatment of respiratory disease Apr 09, 2021

(Expired)

Novartis
Seebri Neohaler US8029768 Treatment of respiratory diseases Apr 09, 2021

(Expired)

Novartis
Lonhala Magnair Kit US6962151 Inhalation nebulizer Oct 27, 2020

(Expired)

Sumitomo Pharma Am
Seebri Neohaler US6528678 Phosgene-free process for preparing carbamates Apr 24, 2018

(Expired)

Novartis
Seebri Neohaler US6582678 Carrier particles for use in dry powder inhalers Apr 24, 2018

(Expired)

Novartis
Seebri Neohaler US6521260 Carrier particles for use in dry powder inhalers Jan 31, 2016

(Expired)

Novartis



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Glycopyrrolate's patents.

Given below is the list recent legal activities going on the following patents of Glycopyrrolate.

Activity Date Patent Number
Patent litigations
Maintenance Fee Reminder Mailed 24 Jun, 2024 US8303991(Litigated)
Expire Patent 04 Dec, 2023 US8048451
Maintenance Fee Reminder Mailed 19 Jun, 2023 US8048451
Expire Patent 27 Mar, 2023 US8956661
Payment of Maintenance Fee, 12th Year, Large Entity 22 Mar, 2023 US8029768
Maintenance Fee Reminder Mailed 10 Oct, 2022 US8956661
Expire Patent 18 Jul, 2022 US7736670
Expire Patent 13 Jun, 2022 US9962338
Expire Patent 10 May, 2022 US9931304
Maintenance Fee Reminder Mailed 31 Jan, 2022 US7736670


Glycopyrrolate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Glycopyrrolate Generic API Manufacturers

Several generic applications have been filed for Glycopyrrolate. The first generic version for Glycopyrrolate was by Watson Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Msn Laboratories Private Ltd and was approved on Apr 8, 2025.

Given below is the list of companies who have filed for Glycopyrrolate generic, along with the locations of their manufacturing plants worldwide.